Femoral Artery Complications after Cardiac Catheterization: A Study of Patient Profile

Annals of Vascular Surgery

Volumn 24, Issue 3, 2010, Pages 328-335

  Castillo Sang, Mario ^a   Tsang, Albert W ^a   Almaroof, Babatunde ^a   Cireddu, James ^a   Sferra, Joseph ^a,b   Zelenock, Gerald B ^a   Engoren, Milo ^b   Kasper, Gregory ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b ST VINCENT MERCY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN;

ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; COMORBIDITY; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DEMOGRAPHY; FALSE ANEURYSM; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEMATOMA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; VASCULAR ACCESS;

AGED; ANTICOAGULANTS; CORONARY ARTERY DISEASE; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEMATOMA; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PUNCTURES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TICLOPIDINE;

EID: 77649338222     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.06.025     Document Type: Article

References (32)

1. Assali A.R., Sdringola S., Moustapha A., et al. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices. Catheter Cardiovasc Interv 58 (2003) 1-5
2. Boccalandro F., Assali A., Fujise K., et al. Vascular access site complications with the use of closure devices in patients treated with platelet glycoprotein IIb/IIIa inhibitors during rescue angioplasty. Catheter Cardiovasc Interv 63 (2004) 284-289
3. Jacobson K.M., Hall Long K., McMurtry E.K., et al. The economic burden of complications during percutaneous coronary intervention. Qual Saf Health Care 16 (2007) 154-159
4. Scanlon P.J., Faxon D.P., Audet A.M., et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33 (1999) 1756-1824
5. Fruhwirth J., Pascher O., Hauser H., et al. Local vascular complications after iatrogenic femoral artery puncture. [in German]. Wien Klin Wochenschr 108 (1996) 196-200
6. Jackson J.L., Meyer G.S., and Pettit T. Complications from cardiac catheterization: analysis of a military database. Mil Med 165 (2000) 298-301
7. Kaufman J., Moglia R., Lacy C., et al. Peripheral vascular complications from percutaneous transluminal coronary angioplasty: a comparison with transfemoral cardiac catheterization. Am J Med Sci 297 (1989) 22-25
8. Kresowik T.F., Khoury M.D., Miller B.V., et al. A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. J Vasc Surg 13 (1991) 328-333
9. Sreeram S., Lumsden A.B., Miller J.S., et al. Retroperitoneal hematoma following femoral arterial catheterization: a serious and often fatal complication. Am Surg 59 (1993) 94-98
10. Chandrasekar B., Doucet S., Bilodeau L., et al. Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv 52 (2001) 289-295
11. Lumsden A.B., Miller J.M., Kosinski A.S., et al. A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. Am Surg 60 (1994) 132-137
12. Muller D.W., Shamir K.J., Ellis S.G., et al. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 69 (1992) 63-68
13. Waksman R., King III S.B., Douglas J.S., et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 75 (1995) 886-889
14. Dauerman H.L., Applegate R.J., and Cohen D.J. Vascular closure devices: the second decade. J Am Coll Cardiol 50 (2007) 1617-1626
15. Blankenship J.C., Hellkamp A.S., Aguirre F.V., et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial. Am J Cardiol 81 (1998) 36-40
16. Omoigui N.A., Califf R.M., Pieper K., et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). J Am Coll Cardiol 26 (1995) 922-930
17. Hsieh F.Y. Sample size tables for logistic regression. Stat Med 8 (1989) 795-802
18. Nagelkerke N.J.D. A note on a general definition of the coefficient of determination. Biometrika 78 (1991) 691-692
19. Rosenbaum P.R., and Rubin D.B. The bias due to incomplete matching. Biometrics 41 (1985) 103-116
20. Rao S.V., O'Grady K., Pieper K.S., et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 47 (2006) 809-816
21. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. J Am Coll Cardiol Intv 1 (2008) 317-326
22. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv 67 (2006) 556-562
23. Yatskar L., Selzer F., Feit F., et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 69 (2007) 961-966
24. Ndrepepa G., Berger P.B., Mehilli J., et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51 (2008) 690-697
25. Arora N., Matheny M.E., Sepke C., et al. A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 153 (2007) 606-611
26. Ates M., Sahin S., Konuralp C., et al. Evaluation of risk factors associated with femoral pseudoaneurysms after cardiac catheterization. J Vasc Surg 43 (2006) 520-524
27. Piper W.D., Malenka D.J., Ryan Jr. T.J., et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 145 (2003) 1022-1029
28. Bonello L., Lemesle G., De Labriolle A., et al. Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous coronary intervention. Am J Cardiol 102 (2008) 1318-1322
29. Koreny M., Riedmuller E., Nikfardjam M., et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291 (2004) 350-357
30. Nikolsky E., Mehran R., Halkin A., et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 44 (2004) 1200-1209
31. Chevalier B., Lancelin B., Koning R., et al. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv 58 (2003) 285-291
32. Exaire J.E., Dauerman H.L., Topol E.J., et al. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices. Am Heart J 147 (2004) 31-34